Understanding the underlying causes of AMR and HCAI, identifying the best methods to improve antimicrobial use, their potential impact and their cost-effectiveness
The Unit is a partnership between Imperial College and Public Health England. It has been funded by NIHR for a further five-year term from 1 April 2020 and builds on an existing critical mass of research conducted between 01 April 2014 - 31 March 2020.
The Unit’s Director is Professor Alison Holmes and its PHE lead is Matt Ellington. Find out more about our people here.
The Unit’s current partners are:
